For: | Vita FD, Martino ND, Fabozzi A, Laterza MM, Ventriglia J, Savastano B, Petrillo A, Gambardella V, Sforza V, Marano L, Auricchio A, Galizia G, Ciardiello F, Orditura M. Clinical management of advanced gastric cancer: The role of new molecular drugs. World J Gastroenterol 2014; 20(40): 14537-14558 [PMID: 25356019 DOI: 10.3748/wjg.v20.i40.14537] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i40/14537.htm |
Number | Citing Articles |
1 |
Hansoo Park, Sung-Yup Cho, Hyerim Kim, Deukchae Na, Jee Yun Han, Jeesoo Chae, Changho Park, Ok-Kyoung Park, Seoyeon Min, Jinjoo Kang, Boram Choi, Jimin Min, Jee Young Kwon, Yun-Suhk Suh, Seong-Ho Kong, Hyuk-Joon Lee, Edison T. Liu, Jong-Il Kim, Sunghoon Kim, Han-Kwang Yang, Charles Lee.
Genomic alterations in
BCL2L1
and
DLC1
contribute to drug sensitivity in gastric cancer
. Proceedings of the National Academy of Sciences 2015; 112(40): 12492 doi: 10.1073/pnas.1507491112
|
2 |
Dirk Graf, Dieter Häussinger. Ösophaguskarzinom: Therapie ist hoch diversifiziert. Deutsches Ärzteblatt Online 2015; doi: 10.3238/PersOnko.2015.09.25.02
|
3 |
Renu Verma, Puja Sakhuja, Ritu Srivastava, Prakash Chand Sharma. Implication of expression of MMR proteins and clinicopathological characteristics in gastric cancer. Asia-Pacific Journal of Oncology 2020; : 1 doi: 10.32948/ajo.2020.12.30
|
4 |
Giandomenico Roviello, Karol Polom, Roberto Petrioli, Luigi Marano, Daniele Marrelli, Giovanni Paganini, Vinno Savelli, Daniele Generali, Lorenzo De Franco, Andrea Ravelli, Franco Roviello. Monoclonal antibodies-based treatment in gastric cancer: current status and future perspectives. Tumor Biology 2016; 37(1): 127 doi: 10.1007/s13277-015-4408-9
|
5 |
ZHONGYUAN QU, XIANG ZOU, XIUJUAN ZHANG, JIEJING SHENG, YUMENG WANG, JIAQI WANG, CHAO WANG, YUBIN JI. Chelidonine induces mitotic slippage and apoptotic-like death in SGC-7901 human gastric carcinoma cells. Molecular Medicine Reports 2016; 13(2): 1336 doi: 10.3892/mmr.2015.4683
|
6 |
Ilguk Min, Kangpa Lee, Haeryong Chang, Jinyoung Moon. Pinus densiflora Gnarl Inhibits Migration through Suppression of Protein Kinase C in C6 Glioma Cells. Korean Journal of Acupuncture 2015; 32(2): 51 doi: 10.14406/acu.2015.006
|
7 |
Olga Sokolova, Michael Naumann. NF‐κB Signaling in Gastric Cancer. Toxins 2017; 9(4): 119 doi: 10.3390/toxins9040119
|
8 |
Juyoung Kim, Kyung Hee Jung, Hong Hua Yan, Min Ji Cheon, Sunmi Kang, Xing Jin, Sunghyouk Park, Myung Sook Oh, Soon-Sun Hong. Artemisia Capillaris leaves inhibit cell proliferation and induce apoptosis in hepatocellular carcinoma. BMC Complementary and Alternative Medicine 2018; 18(1) doi: 10.1186/s12906-018-2217-6
|
9 |
Weijing Sun, Li Yan. Gastric cancer: current and evolving treatment landscape. Chinese Journal of Cancer 2016; 35(1) doi: 10.1186/s40880-016-0147-6
|
10 |
A. Scott Paulson, Lisa M. Hess, Astra M. Liepa, Zhanglin Lin Cui, Kathleen M. Aguilar, Jamyia Clark, William Schelman. Ramucirumab for the treatment of patients with gastric or gastroesophageal junction cancer in community oncology practices. Gastric Cancer 2018; 21(5): 831 doi: 10.1007/s10120-018-0796-z
|
11 |
Changyu Sun, Zhihao Zhang, Ping He, Yan Zhou, Xuhua Xie. Involvement of PI3K/Akt pathway in the inhibition of hepatocarcinoma cell invasion and metastasis induced by SASH1 through downregulating Shh-Gli1 signaling. The International Journal of Biochemistry & Cell Biology 2017; 89: 95 doi: 10.1016/j.biocel.2017.06.006
|
12 |
Xuefen Lei, Feng Wang, Yang Ke, Dong Wei, Hou Gu, Zhixian Zhang, Lifeng Jiang, Li Lv, Jie Lin, Lin Wang. The role of antiangiogenic agents in the treatment of gastric cancer. Medicine 2017; 96(10): e6301 doi: 10.1097/MD.0000000000006301
|
13 |
Sarah L. Greig, Gillian M. Keating. Ramucirumab: A Review in Advanced Gastric Cancer. BioDrugs 2015; 29(5): 341 doi: 10.1007/s40259-015-0138-1
|
14 |
Pedro Nazareth Aguiar, Thiago Pimentel Muniz, Raelson Rodrigues Miranda, Hakaru Tadokoro, Nora Manoukian Forones, Ines-de-Paula Monteiro, Pedro Castelo-Branco, Yelena Y Janjigian, Ramon Andrade de Mello. Current Advances in Targeted Therapies for Metastatic Gastric Cancer: Improving Patient Care. Future Oncology 2016; 12(6): 839 doi: 10.2217/fon.15.348
|
15 |
Minoru Tomizawa, Fuminobu Shinozaki, Yasufumi Motoyoshi, Takao Sugiyama, Shigenori Yamamoto, Naoki Ishige. CCAAT/enhancer-binding protein α decreases the viability of gastric cancer cells. Oncology Letters 2017; 13(6): 4322 doi: 10.3892/ol.2017.5987
|
16 |
Yong Zhang, Chun Han, Juan Li, Li Zhang, Lijie Wang, Sisi Ye, Yi Hu, Li Bai. Efficacy and safety for Apatinib treatment in advanced gastric cancer: a real world study. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-13192-8
|
17 |
Xiaodong Wang, Yu Liu, Yuwen Diao, Ningning Gao, Yanyan Wan, Jingjing Zhong, Huali Zheng, Zhulin Wang, Guangyi Jin. Gastric cancer vaccines synthesized using a TLR7 agonist and their synergistic antitumor effects with 5-fluorouracil. Journal of Translational Medicine 2018; 16(1) doi: 10.1186/s12967-018-1501-z
|
18 |
Weiyu Liu, Yong Cao, Yadi Guan, Changqing Zheng. BST2 promotes cell proliferation, migration and induces NF-κB activation in gastric cancer. Biotechnology Letters 2018; 40(7): 1015 doi: 10.1007/s10529-018-2562-z
|
19 |
Laís Reis-das-Mercês, Tatiana Vinasco-Sandoval, Rafael Pompeu, Aline Cruz Ramos, Ana K. M. Anaissi, Samia Demachki, Paulo Pimentel de Assumpção, Amanda F. Vidal, Ândrea Ribeiro-dos-Santos, Leandro Magalhães. CircRNAs as Potential Blood Biomarkers and Key Elements in Regulatory Networks in Gastric Cancer. International Journal of Molecular Sciences 2022; 23(2): 650 doi: 10.3390/ijms23020650
|
20 |
FAN ZHANG, XINGWU YANG, LIANHONG LI, LEI SUN, BO WANG, XIAOTANG YU. Epidermal growth factor receptor expression and gene copy number analysis in gastric carcinoma samples from Chinese patients. Oncology Letters 2016; 11(1): 173 doi: 10.3892/ol.2015.3875
|
21 |
Giandomenico Roviello, Roberto Petrioli, Pietro Rosellini, Andrea Giovanni Multari, Raffaele Conca, Giovanni Paganini, Giorgio Chiriacò, Michele Aieta. The influence of prior ramucirumab treatment on the clinical activity of FOLFIRI as third-line therapy in patients with metastatic gastric Cancer. Investigational New Drugs 2019; 37(3): 524 doi: 10.1007/s10637-019-00725-3
|
22 |
Wanren Peng, Fenglin Zhang, Zishu Wang, Dongliang Li, Yifu He, Zhongliang Ning, Lili Sheng, Jidong Wang, Xiaoyang Xia, Changjun Yu, Zian Wang, Yong Zhao, Hui Liang, Bing Hu, Cuiling Sun, Daoqin Wang, Yunsheng Cheng, Ming Pan, Liming Xia, Xinglai Guo, Yanshun Zhang, Zhiqiang Hu, Xinzhong Li, Lin Lu, Jun Zhang, Hong Qian, Hua Xie, Guoping Sun. <p>Large Scale, Multicenter, Prospective Study of Apatinib in Advanced Gastric Cancer: A Real-World Study from China</p>. Cancer Management and Research 2020; : 6977 doi: 10.2147/CMAR.S249153
|
23 |
Bo Chen, Qi-Cong Luo, Jian-Bo Chen, Li-E Lin, Ming-Xu Luo, Hong-Yue Ren, Pei-Qiong Chen, Lian-Guo Shi. Efficient isolation and proteomic analysis of cell plasma membrane proteins in gastric cancer reveal a novel differentiation and progression related cell surface marker, R-cadherin. Tumor Biology 2016; 37(9): 11775 doi: 10.1007/s13277-016-5032-z
|
24 |
Federica Grillo, Matteo Fassan, Francesca Sarocchi, Roberto Fiocca, Luca Mastracci. HER2 heterogeneity in gastric/gastroesophageal cancers: From benchside to practice. World Journal of Gastroenterology 2016; 22(26): 5879-5887 doi: 10.3748/wjg.v22.i26.5879
|
25 |
Angelica Petrillo, Luca Pompella, Giuseppe Tirino, Annalisa Pappalardo, Maria Maddalena Laterza, Marianna Caterino, Michele Orditura, Fortunato Ciardiello, Eva Lieto, Gennaro Galizia, Carlo Castoro, Ferdinando De Vita. Perioperative Treatment in Resectable Gastric Cancer: Current Perspectives and Future Directions. Cancers 2019; 11(3): 399 doi: 10.3390/cancers11030399
|
26 |
Luis Gabriel Parra-Lara, Juan Camilo Falla-Martínez, Daniel Francisco Isaza-Pierotti, Diana Marcela Mendoza-Urbano, Andrés R. Tangua-Arias, Juan Carlos Bravo, Luis Eduardo Bravo, Ángela R. Zambrano. Gastric adenocarcinoma burden, trends and survival in Cali, Colombia: A retrospective cohort study. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1069369
|
27 |
Rui Zhao, Tongtong Zhang, Weidong Xi, Xiaobin Sun, Lingxiao Zhou, Yuanbiao Guo, Cong Zhao, Yu Bao. Human chorionic gonadotropin promotes cell proliferation through the activation of c‑Met in gastric cancer cells. Oncology Letters 2018; doi: 10.3892/ol.2018.9215
|
28 |
Yun‐Ji Jeung, Kyeong Lee, Hyo Jin Lee, Eunah Kim, Myung Jin Son, Jiwon Ahn, Han‐Gyeul Kim, Wantae Kim, Ho‐Joon Lee, Jin Man Kim, Kyung‐Sook Chung. Cationic amino acid transporter PQLC2 is a potential therapeutic target in gastric cancer. Cancer Science 2019; 110(4): 1453 doi: 10.1111/cas.13966
|
29 |
Xiaojing Deng, Hailun Zheng, Dapeng Li, Yongju Xue, Qizhi Wang, Shanjun Yan, Yu Zhu, Min Deng. MicroRNA-34a regulates proliferation and apoptosis of gastric cancer cells by targeting silent information regulator 1. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.5920
|
30 |
Csongor G. Lengyel, Sadaqat Hussain, Andreas Seeber, Sara Jamil Nidhamalddin, Dario Trapani, Baker S. Habeeb, Essam Elfaham, Syed Ayub Mazher, Fahmi Seid, Shah Z. Khan, Khalid El Bairi, Andrew Odhiambo, Sara C. Altuna, Angelica Petrillo. FGFR Pathway Inhibition in Gastric Cancer: The Golden Era of an Old Target?. Life 2022; 12(1): 81 doi: 10.3390/life12010081
|
31 |
Nadine Schulte, Matthias P. Ebert, Nicolai Härtel. Gastric Cancer: New Drugs - New Strategies. Gastrointestinal Tumors 2014; 1(4): 180 doi: 10.1159/000380786
|
32 |
Chenggang Yang, Wanlei Zheng, Wenfeng Du. CXCR3A contributes to the invasion and metastasis of gastric cancer cells. Oncology Reports 2016; 36(3): 1686 doi: 10.3892/or.2016.4953
|
33 |
MINORU TOMIZAWA, FUMINOBU SHINOZAKI, YASUFUMI MOTOYOSHI, TAKAO SUGIYAMA, SHIGENORI YAMAMOTO, NAOKI ISHIGE. Gastric cancer cell proliferation is suppressed by frizzled-2 short hairpin RNA. International Journal of Oncology 2015; 46(3): 1018 doi: 10.3892/ijo.2015.2830
|
34 |
Giandomenico Roviello, Roberto Petrioli, Luigi Marano, Karol Polom, Daniele Marrelli, Armando Perrella, Franco Roviello. Angiogenesis inhibitors in gastric and gastroesophageal junction cancer. Gastric Cancer 2016; 19(1): 31 doi: 10.1007/s10120-015-0537-5
|
35 |
Ugur Sahin, Martin Schuler, Heike Richly, Stefan Bauer, Anna Krilova, Tobias Dechow, Markus Jerling, Magdalena Utsch, Christoph Rohde, Karl Dhaene, Christoph Huber, Özlem Türeci. A phase I dose-escalation study of IMAB362 (Zolbetuximab) in patients with advanced gastric and gastro-oesophageal junction cancer. European Journal of Cancer 2018; 100: 17 doi: 10.1016/j.ejca.2018.05.007
|